Abstract
Introduction
In Parkinson’s disease (PD), rapid eye movement (REM) sleep behavior disorder (RBD) might either precede the appearance of motor symptoms, or develop during the disease course. PD patients with RBD are characterized by a higher burden of cognitive impairment and hallucinations. However, few studies have analyzed the clinical characteristics of PD patients according to the timeline of RBD onset.
Methods
PD patients have been retrospectively enrolled. Presence and onset of probable RBD (pRBD) has been evaluated using RBD Screening Questionnaire (score ≥ 6). Presence of Mild Cognitive Impairment (MCI) at baseline has been evaluated using the MDS criteria level II. Presence of motor complications and hallucinations has been evaluated at a 5-year follow-up.
Results
A total of 115 PD patients (65 men, 56.5%; mean age 62.5 ± 9.7 years; mean disease duration 3.7 ± 3.9 years) have been enrolled. Out of these, 63 fulfilled the diagnosis of pRBD (54.8%) with 21 (33.3%) reporting the RBD onset before the onset of the motor symptoms (PD-RBDpre), and 42 (66.7%) after the motor symptoms (PD-RBDpost). At enrolment presence of MCI was associated with PD-RBDpre patients (OR 5.04; 95% CI 1.33–19.05; p value 0.02). At follow-up, a higher risk of developing hallucinations was also associated with PD-RBDpre (OR 4.68; 95% CI 1.24–17.63; p = 0.022).
Conclusions
PD patients with RBD occurring before the onset of motor symptoms represent a subgroup of patients with a more severe cognitive phenotype and with a higher risk of developing hallucinations along the disease course, with significant implications in terms of prognostic stratification and therapeutic approach.
Similar content being viewed by others
Data availability statement
The data supporting the findings of this study are available on request from the corresponding author.
References
Zhang X, Sun X, Wang J, Tang L, Xie A (2017) Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson’s disease: a meta and meta-regression analysis. Neurol Sci. https://doi.org/10.1007/s10072-016-2744-1
Jozwiak N, Postuma RB, Montplaisir J, Latreille V, Panisset M, Chouinard S, Bourgouin P-A, Gagnon J-F (2017) REM sleep behavior disorder and cognitive impairment in Parkinson’s disease. Sleep. https://doi.org/10.1093/sleep/zsx101
Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C (2011) Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 77:1048–1054. https://doi.org/10.1212/WNL.0b013e31822e560e
Cicero CE, Giuliano L, Sgroi R, Squillaci R, Terravecchia C, Vancheri E, Todaro V, Reitano P, Rizzo S, Luca A, Mostile G, Paradisi V, Zappia M, Nicoletti A, Italian Society of General Medicine of Catania Study Group (2021) Prevalence of isolated RBD in the city of Catania, Italy: a population-based study. J Clin Sleep Med 17:2241–2248. https://doi.org/10.5664/jcsm.9416
Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi P-H, Plazzi G, Montplaisir J, Boeve B (2018) REM sleep behaviour disorder. Nat Rev Dis Primer 4:19. https://doi.org/10.1038/s41572-018-0016-5
Stang CD, Mullan AF, Hajeb M, Camerucci E, Turcano P, Martin P, Mielke MM, Josephs KA, Bower JH, St Louis EK, Boeve BF, Savica R (2021) Timeline of rapid eye movement sleep behavior disorder in overt alpha-synucleinopathies. Ann Neurol 89:293–303. https://doi.org/10.1002/ana.25952
Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung K-Y, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St. Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon J-F, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142:744–759. https://doi.org/10.1093/brain/awz030
Terzaghi M, Toscano G, Casoni F, Picascia M, Arnaldi D, Rustioni V, Versino M, Sinforiani E, Manni R (2019) Assessment of cognitive profile as a prodromal marker of the evolution of rapid eye movement sleep behavior disorder. Sleep 42:zsz103. https://doi.org/10.1093/sleep/zsz103
Horsager J, Andersen KB, Knudsen K, Skjærbæk C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, Göder R, Brooks DJ, Berg D, Borghammer P (2020) Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study. Brain 143:3077–3088. https://doi.org/10.1093/brain/awaa238
Ferri R, Cosentino FII, Pizza F, Aricò D, Plazzi G (2014) The timing between REM sleep behavior disorder and Parkinson’s disease. Sleep Breath 18:319–323. https://doi.org/10.1007/s11325-013-0887-3
Long K, Wan C, Xiang Y, Liu J, Xu Q, Sun Q, Wang Z, Tian Y, Fang L, Yang Y, Yan X, Tang B, Guo J (2020) Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder. Front Neurol 11:979. https://doi.org/10.3389/fneur.2020.00979
Gong Y, Xiong K-P, Mao C-J, Shen Y, Hu W-D, Huang J-Y, Han F, Chen R, Liu C-F (2014) Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder. Sleep Med 15:647–653. https://doi.org/10.1016/j.sleep.2013.12.021
Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752
Marelli S, Rancoita PMV, Giarrusso F, Galbiati A, Zucconi M, Oldani A, Di Serio C, Ferini-Strambi L (2016) National validation and proposed revision of REM sleep behavior disorder screening questionnaire (RBDSQ). J Neurol 263:2470–2475. https://doi.org/10.1007/s00415-016-8285-y
Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713. https://doi.org/10.1016/j.sleep.2011.01.015
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356. https://doi.org/10.1002/mds.24893
Yan Y-Y, Lei K, Li Y-Y, Liu X-F, Chang Y (2019) The correlation between possible RBD and cognitive function in Parkinson’s disease patients in China. Ann Clin Transl Neurol 6:848–853. https://doi.org/10.1002/acn3.747
Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C, Terzaghi M, Ossola M, Martignoni E, Moglia A, Nappi G (2005) Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 20:1439–1448. https://doi.org/10.1002/mds.20582
Terzaghi M, Sinforiani E, Zucchella C, Zambrelli E, Pasotti C, Rustioni V, Manni R (2008) Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Med 9:343–351. https://doi.org/10.1016/j.sleep.2007.06.013
Gagnon J-F, Fantini ML, Bédard M-A, Petit D, Carrier J, Rompré S, Décary A, Panisset M, Montplaisir J (2004) Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology 62:401–406. https://doi.org/10.1212/01.wnl.0000106460.34682.e9
Mostile G, Giuliano L, Monastero R, Luca A, Cicero CE, Donzuso G, Dibilio V, Baschi R, Terranova R, Restivo V, Sofia V, Zappia M, Nicoletti A (2019) Electrocortical networks in Parkinson’s disease patients with Mild Cognitive Impairment. The PaCoS study. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2019.03.027
Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB (2014) People with Parkinson’s disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 29:1258–1264. https://doi.org/10.1002/mds.25924
Arnulf I, Neutel D, Herlin B, Golmard JL, Leu-Semenescu S, Cochen de Cock V, Vidailhet M (2015) Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease. Sleep 38(10):1529–1535. https://doi.org/10.5665/sleep.5040
Crowe SF, Stranks EK (2018) The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Archi Clin Neuropsychol 33(7):901–911. https://doi.org/10.1093/arclin/acx120
Nègre-Pagès L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lépine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov Dis 25(2):157–166. https://doi.org/10.1002/mds.22760
Lenka A, Hegde S, Jhunjhunwala KR, Pal PK (2016) Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson’s disease: a review. Parkinsonism Relat Disord 22:1–8. https://doi.org/10.1016/j.parkreldis.2015.11.018
Liu Y, Zhu X-Y, Zhang X-J, Kuo S-H, Ondo WG, Wu Y-C (2017) Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder. Transl Neurodegener 6:35. https://doi.org/10.1186/s40035-017-0105-5
Barrett MJ, Blair JC, Sperling SA, Smolkin ME, Druzgal TJ (2018) Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease. Neurology 90:e1618–e1626. https://doi.org/10.1212/WNL.0000000000005421
Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G (2010) A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 67:996–1001. https://doi.org/10.1001/archneurol.2010.166
Gallagher DA, Parkkinen L, O’Sullivan SS, Spratt A, Shah A, Davey CC, Bremner FD, Revesz T, Williams DR, Lees AJ, Schrag A (2011) Testing an aetiological model of visual hallucinations in Parkinson’s disease. Brain 134:3299–3309. https://doi.org/10.1093/brain/awr225
Janzen J, D. van ’t Ent, A.W. Lemstra, H.W. Berendse, F. Barkhof, E.M. Foncke, (2012) The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study. J Neurol 259(1):147–154. https://doi.org/10.1007/s00415-011-6149-z
Chambers NE, Lanza K, Bishop C (2020) Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of Parkinson’s disease. Front Pharmacol 10:1494. https://doi.org/10.3389/fphar.2019.01494
Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79–92
Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/s0197-4580(02)00065-9
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
CEC: conception and design of the study, acquisition of data, analysis and interpretation of data, drafting of the article; AL: acquisition of data, analysis and interpretation of data, critical review of the article; GM: acquisition of data, analysis and interpretation of data, critical review of the article; GD: acquisition of data, analysis and interpretation of data, critical review of the article; LG: acquisition of data, analysis and interpretation of data, critical review of the article; MZ: analysis and interpretation of data, critical review of the article; AN: conception and design of the study, analysis and interpretation of data, critical review of the article.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standards
All the patients provided written informed consent to participate in the study. The study has been approved by the Ethical Committee of the AOU Policlinico G. Rodolico-San Marco (111/2019/PO) and has been conducted in accordance to the Declaration of Helsinki.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cicero, C.E., Luca, A., Mostile, G. et al. Influence of RBD onset on the clinical characteristics of Parkinson’s disease patients: a retrospective study. J Neurol 270, 3171–3178 (2023). https://doi.org/10.1007/s00415-023-11659-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-11659-5